期刊文献+

MMP9基因单核苷酸多态性与鼻咽癌遗传易感性的关系

Relationship between MMP9 gene polymorphisms and genetic susceptibility in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的研究MMP9基因单核苷酸多态性与广东人鼻咽癌患病风险及临床病理分期的关系。方法以聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)分析方法检测433例鼻咽癌患者和437例健康对照MMP9基因C-1562T和第6外显子R279Q基因型。结果吸烟显著增加鼻咽癌的患病风险(OR=4.01,95%CI=2.86-5.63)。MMP9基因C-1562T和R279Q基因型频率病例组与对照组相似,均未能增加鼻咽癌的发病风险,-1562CT/TT基因型相对于CC基因型Ad OR=0.99,95%CI=0.70-1.39;279RQ/QQ基因型相对于RR基因型OR=0.96,95%CI=0.70-1.32;而且与吸烟增加鼻咽癌发病风险无交互作用。鼻咽癌病例组中,-1562CT/TT和RQ/QQ基因型并未表现出更高的T分期(经年龄、性别和吸烟校正后的OR值分别为1.23和0.84,P>0.05)和淋巴结转移潜能(经年龄、性别和吸烟校正后的OR值分别为0.88和0.68,P>0.05)。结论 MMP9基因C-1562T和第6外显子R279Q多态性与广东地区鼻咽癌患病风险无关,可能不是广东人鼻咽癌发病遗传易感因素。 Objective To investigate the correlation of the MMP9 SNPs with genetic susceptibility and development of NPC. Methods The MMP9 C-1562T and exon 6 R279Q genotypes in 433 NPC patients and 437 controls from a Guangdong population using PCR-RFLP were analyzed, and also studied the association between the genotypes and clinicopathologi- cal features among cases. Results Smoking significantly increased the risk of NPC development (OR = 4.01, 95% CI = 2.86- 5.63). The distribution of C-1562T and R279Q genotypes was not significantly associated with the risk of NPC (OR = 0.99, 95% CI = 0.70-1.39 for -1562 CT/TY genotypes versus CC genotype; OR = 0.96, 95% CI = 0.70-1.32 for 279 RQ/QQ genotypes versus RR genotype), neither the genotypes combination. When stratified by smoking status, SNPs did not show any significant in- fluence on the risk of NPC development. No significant association was found between clinicopathological features and the two poly- morphisms in NPC patients. Conclusion MMP9 gene C-1562T and exon6 R279Q polymorphisms may be not a genetic susceptibili- ty factor to NPC in Guangdong population.
出处 《解剖学研究》 CAS 2013年第5期335-338,342,共5页 Anatomy Research
基金 国家自然科学基金(81202135)
关键词 基质金属蛋白酶 多态性 鼻咽肿瘤 Matrix metalloproteinase-9 Polymorphisms Nasopharyngeal neoplasms
  • 相关文献

参考文献2

二级参考文献14

  • 1Murray GI,Duncan ME,Arbuckle E,et al.Matrix metalloproteinases and their inhibitors in gastric cancer [J].Gut,1998,43(6): 791- 797.
  • 2Nomura H,Fujimoto N,Seiki M,et al.Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas [J].Int J Cancer,1996,69(1): 9- 16.
  • 3Bergers G,Brekken R,McMahon G,et al.Matrix metalloprotei nase 9 triggers the angiogenic switch during carcinogenesis [J].Nature Cell Biol,2000,2(10): 737- 744.
  • 4Belotti D,Paganoni P,Manenti L,et al.Matrix metalloprote inases (MMP-9 and MMP-2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation [J].Cancer Res,2003,63(17): 5224- 5229.
  • 5Zhang B,Ye S,Herrmann SM,et al.Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis [J].Circulation,1999,99(14): 1788- 1794.
  • 6Yu C,Pan K,Xing D,et al.Correlation between a single nucleotide polymorphism in the matrix metalloproteinase 2 promoter and risk of lung cancer [J].Cancer Res,2002,62(22): 6430- 6433.
  • 7Miao X,Yu C,Tan W,et al.A functional polymorphism in the matrix metalloproteinase 2 gene promoter ( 1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma [J].Cancer Res,2003,63(14): 3987- 3990.
  • 8Zhou Y,Yu C,Miao X,et al.Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 genes [J].Carcinogenesis,2004,25(3): 399- 404.
  • 9Roder DM.The epidemiology of gastric cancer [J].Gastric Cancer,2002,5(Suppl 1): 5-11.
  • 10Reich DE,Lander ES.On the allelic spectrum of human disease [J].Trends Genet,2001,17(9): 502- 510.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部